标题
Deutetrabenazine for the treatment of Huntington’s chorea
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume -, Issue -, Pages 1-7
出版商
Informa UK Limited
发表日期
2018-07-12
DOI
10.1080/14737175.2018.1500178
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacokinetics, Metabolism and Safety of Deuterated L-DOPA (SD-1077)/Carbidopa (CD) Compared to L-DOPA/CD following single oral dose administration in Healthy Subjects
- (2018) Frank Schneider et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors
- (2018) Nicki Niemann et al. DRUGS
- Neurological diseases and risk of suicide attempt: a case–control study
- (2018) Astrid Eliasen et al. JOURNAL OF NEUROLOGY
- Tardive dyskinesia: Out of the shadows
- (2018) Robert A. Hauser et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease
- (2018) Marissa Dean et al. Drug Design Development and Therapy
- Deuterated drugs; updates and obviousness analysis
- (2017) Graham S. Timmins EXPERT OPINION ON THERAPEUTIC PATENTS
- Treatment options for chorea
- (2017) H. Bashir et al. Expert Review of Neurotherapeutics
- First deuterated drug approved
- (2017) Charles Schmidt NATURE BIOTECHNOLOGY
- Randomized controlled trial of deutetrabenazine for tardive dyskinesia
- (2017) Hubert H. Fernandez et al. NEUROLOGY
- Treatment options for chorea
- (2017) H. Bashir et al. Expert Review of Neurotherapeutics
- Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea
- (2017) Samuel Frank et al. JAMA Neurology
- Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia
- (2016) Dhanya Vijayakumar et al. DRUGS
- Dopamine depleters in the treatment of hyperkinetic movement disorders
- (2016) Joseph Jankovic EXPERT OPINION ON PHARMACOTHERAPY
- Deutetrabenazine for Treatment of Chorea in Huntington Disease
- (2016) Michael D. Geschwind et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Progression of motor subtypes in Huntington’s disease: a 6-year follow-up study
- (2016) M. Jacobs et al. JOURNAL OF NEUROLOGY
- Deuterated drugs draw heavier backing
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Deutetrabenazine—Not a Revolution but Welcome Evolution for Treating Chorea in Huntington Disease
- (2016) Ralf Reilmann JAMA Neurology
- Treating the whole body in Huntington's disease
- (2015) Jeffrey B Carroll et al. LANCET NEUROLOGY
- Chorea associated with Huntington's disease: To treat or not to treat?
- (2014) Joseph Jankovic et al. MOVEMENT DISORDERS
- Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature
- (2012) Jack J. Chen et al. CLINICAL THERAPEUTICS
- Analysis ofCYP2D6genotype and response to tetrabenazine
- (2012) Raja Mehanna et al. MOVEMENT DISORDERS
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started